In major development in pharma, halt order enforced on production and sale of 35 fixed-dose combination drugs

India's drug regulator, CDSCO, has ordered a halt to the production, sale, and distribution of 35 fixed-dose combination (FDC) drugs due to safety concerns. These drugs, including pain relievers and diabetes medications, lacked proper evaluation before approval. The CDSCO has directed state and Union territory regulators to reassess approval procedures, ensuring adherence to the Drugs and Cosmetics Act.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9VDCGWw
via IFTTT